Day 2 :
Medical University of Innsbruck, Austria
Time : 10:00-10:40
Wilhelm Eisner studied Chemistry and Medicine at the University of Cologne, Mainz and Munich. Until 1999, Medical University Munich and since 1999 Medical University Innsbruck. At the LMU Munich he got his general neurosurgical training. In Bern, Munich, Pittsburgh, Cologne he got special training in Electrophysiology, Functional Neurosurgery, Stereotaxy and Radiosurgery. He was a founding member of the team (H J Reulen) who introduced awake craniotomy in Oncologic Neurosurgery in Europe in 1988 in Bern; Swiss and 1991 in Munich, Germany. He has a main concern of functional integrity of neurosurgical patients therefore he built up a reputation in intraoperative electrophysiology internationally in the beginning of the 1990’s. His second and predominant subject is deep brain stimulation in movement disorders and pharmaco resistant pain syndromes, beside psychiatric disorders and radiosurgery. He is the Founder and Head of the Austrian Society of Stereotactic and Functional Neurosurgery, Radiosurgery, Intraoperative Electrophysiology, Intraoperative Imaging beside member of the board of the Austrian Pain Society, Vice President of the German Society of Neuromodulation. He is Lecturer at the Medical University Innsbruck, Mozarteum Salzburg/Innsbruck, Danube University Krems beside many other academic functions. He published more than 100 articles and gained 3788 citations, RG score 35.29, CI 332.
Introduction: In the last 30 years neuromodulation by deep brain stimulation gained widely acceptance starting in the field of movement disorders. In pain syndromes deep brain stimulation is far less effective. The results in nociceptive pain syndromes are around 50% and in neuropathic pain syndromes less than 50%. For the last 25 years the author has focused on neurosurgical pain therapy by neuromodulation.
Material & Methods: We will provide a historical overview on neurosurgical pain therapy of the head and on the pain matrix evolved by imaging studies. Further we will demonstrate our development of deep brain stimulation consisting of two electrodes per cerebral hemisphere and our achievement of pain free patient including normalization of sensory function. Out of 46 treated patients with neuropathic pain syndromes we had a group of 12 patients with neuropathic pain of the face. 50% showed a severe sensory deficit for touch-, pain-, warmth- and cold sensation. All patients had pre- and postoperative neurophysiological-, neuropsychological examination beside of pain questionnaires. Further quantitative sensory testing (QST) in neuropathic areas and normal area in the contralateral face side were performed before and after surgery. We examined six women from 29 to 65 years of age with pure trigeminal neuropathia. All patients were treated with two electrodes in the same side of the pain. One electrode was reaching from a precoronal approach the ventral posteromedial nucleus (VPM) thalamic area and one electrode was inserted from a parietal approach into the posterior limp of the capsula interna by stereotaxy. 3T MRT and stereotactic computed tomography angiography were fused to gain maximum information and safety. Operation was performed under intubation anesthesia. Tractography was showing motor and sensory fiber tracts. All patients got neuropsychological testing of memory and cognition pre- and one year postoperatively to detect stimulation induced changes.
Results: All six patients lost allodynia, hyperpathia and dysesthesia. Pain did not exist anymore. Touch and repeated touch was not provoking pain anymore. All patients gained a relief of the permanent burning pain followed by normalization of sensory function in the face as it has been before the neural trauma. Neuropsychological testing showed no change in memory and cognition before and one year after surgery. We will give examples of the treatment on peripheral neuropathic pain syndromes and central neuropathic pain syndromes such as thalamic pain syndromes.
Conclusion: Our method against neuropathic facial pain is high effective and safe as it is in other neuropathic pain syndromes. More than five years of stable and successful treatment urge to perform prospective randomized and blinded trails.
Neuroscientist, USA and Canadian University of Dubai, UAE
Keynote: Neurophysiological and psychometric data results from executive health coaching and biotechnology applications
Time : 11:00-11:40
Justin James Kennedy is a Brain Coach and a globally recognized Professor of Neuroscience, Executive Coach and Leadership Specialist. With over 20 years of C-Suite executive coaching experience globally in the USA, UK and South Africa, he translates his neuroscience research into practical business skills. His specialties include: coaching on performance leadership to deliver measurable business results; coaching on the business vision, brain management and corporate strategy; advising professionals on how to optimize systemic change and; improving executive brain functions to enhance mental focus, self and team performance. His first book "Brain Triggers" is co-authored by the world’s #1 coach, Dr. Marshall Goldsmith. He has also published innumerable corporate studies that demonstrate how to improve and sustain executive performance. In 2014, he delivered a TED talk on practical ways to control their brain to perform at peak and even increase IQ and memory.
Neurophysiological and cognitive/work performance data generated from a population of C-Suite executives participating in a health coaching program is analysed. The validity of direct current (DC) potential and heart rate variability (HRV) is assessed and compared to leadership and socio- psychometric data. Conclusions regarding resilient health performance and psychological toughness were compared between four groups. Application towards controlling symptoms of burn-out and stress related pathology is presented along with the impact the study had on improved working memory, leadership and socio-cognitive data. The assessment of neurophysiological resilience and psychological adaptation to occupational stress is suggested but would require further validation. Double blind studies are suggested in order to validate a proactive health-care tool for the health insurance industry.
Time : 11:40-12:20
Kim Baden Kristensen is the CEO and Co-founder of Brain+, which specializes in digital therapeutics for brain rehabilitation and remediation, specifically for the recovery of impaired cognitive functions due to injury or disease. It’s award winning Brain+ apps are being clinically tested in Parkinson’s disease, Major depressive disorder and Traumatic brain injury patients, and is being used by Danish national team athletes to enhance cognitive performance. Brain+ is also working on pre-symptomatic detection of Alzheimer’s disease in collaboration with leading European universities, providers, and patient organizations.
Combining the knowledge of neuroscience with computer game design, machine learning, and gaming psychology is set to be a major disruptor in the future of healthcare. Incorporating sensory, cognitive, emotional and behavioral technologies, creators of digital therapeutics are expected to be able to develop games that will improve both health and fundamental cognitive abilities. Neuro-games focused on attention, complex cognitive challenges and mindfulness are just the start as researchers look for solutions for patients suffering from cognitive impairments related to e.g. traumatic brain injury, stroke, depression, Parkinson’s disease, and Alzheimer’s disease. Real computer games + validated neuroscience = improved patient outcomes and quality of care.